Blood test may slash unnecessary antibiotic use in ICUs

NCT ID NCT07481773

Recruiting now Knowledge-focused Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre Source: ClinicalTrials.gov ↗

First seen Apr 12, 2026 · Last updated May 15, 2026 · Updated 3 times

Summary

This study is testing whether a special blood test (biomarker signature) can help doctors in intensive care units (ICUs) make better decisions about when to use antibiotics. About 1,200 ICU patients who have started antibiotics will be randomly assigned to have their treatment guided by this test or by usual care. The goal is to see if the test can reduce antibiotic use while keeping patients safe and improving their recovery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Montreal General Hospital
RECRUITING

Montreal, Quebec, H3G 1A4, Canada

Contact Email: •••••@•••••
Research Institute McGill University Health Centre
RECRUITING

Montreal, Quebec, H4A3J1, Canada

Contact Phone: •••-•••-•••• Email: •••••@•••••
Research Institute of McGill University Health Center (RI-MUHC)
RECRUITING

Montreal, Quebec, H4A 3J1, Canada

Contact Email: •••••@•••••

Contact
Royal Victoria Hospital
RECRUITING

Montreal, Quebec, H4A 3J1, Canada

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

INTENSIVE CARE UNIT (ICU) ADMISSION